UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES
EXCHANGE ACT OF 1934 (Amendment No. 1)
Filed by the Registrant [X] Filed by a Party other than the Registrant [_]
Check the appropriate box:
[_] Preliminary Proxy Statement
[_] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
[_] Definitive Proxy Statement
[X] Definitive Additional Materials
[_] Soliciting Material Pursuant to §240 Rule 14a-12
HESKA CORPORATION
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] | No fee required. |
[_] | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
(1) | Title of each class of securities to which transaction applies: |
(2) | Aggregate number of securities to which transaction applies: |
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
(4) | Proposed maximum aggregate value of transaction: |
(5) | Total fee paid: |
[_] Fee paid previously with preliminary materials:
[_] Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
(1) | Amount Previously Paid: |
(2) | Form, Schedule or Registration Statement No.: |
(3) | Filing Party: |
(4) | Date Filed: |
Heska Corporation
Jon Aagaard, Investor Relations
970.619.3033
investorrelations@heska.com
Heska Corporation Announces its Annual Meeting of Stockholders on April 8, 2020
LOVELAND, CO, March 25, 2020 - Heska Corporation (NASDAQ: HSKA; “Heska” or the “Company”), a provider of advanced veterinary diagnostic and specialty products, announces its 2020 Annual Meeting of Stockholders. The meeting is scheduled for 9 a.m. MT/11 a.m. ET on Wednesday, April 8, 2020 and will be held at Heska corporate headquarters, located at 3760 Rocky Mountain Avenue, Loveland, CO. Stockholders of record as of February 14, 2020, are entitled to notice of, participate in and vote at, the annual meeting. Due to the evolving nature and concern surrounding the coronavirus (COVID-19) and as a prudent, precautionary measure, Heska’s 2020 Annual Meeting of Stockholders may be listened to via webcast and telephone. All stockholders are encouraged to vote on the matters before the Annual Meeting by proxy as described in the Company’s proxy materials provided to stockholders.
2020 Annual Meeting of Stockholders
Heska Corporation Headquarters
Wednesday, April 8, 2020
9 a.m. MT/11 a.m. ET
To access the webcast:
– | Webcast Access: Heska Annual Shareholder Meeting Webcast |
– | The webcast will also be archived on www.heska.com for 90 days. |
To access via telephone:
– | From within the United States, please dial 1-855-327-6837 |
– | From outside of the United States, please dial 1-631-891-4304 |
– | Conference ID: 10008930 |
About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through two business segments. The Core Companion Animal Health ("CCA") segment represents approximately 85% of revenues, and the Other Vaccines and Pharmaceuticals ("OVP") segment represents approximately 15% of revenues, as of December 31, 2019. CCA segment includes Point of Care Laboratory testing instruments and consumables, primarily under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes private label vaccine and pharmaceutical production under third party agreements and channels, primarily for herd animal health.